TrialThe Lancet. Respiratory medicine2025

PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial.

Scott M Norberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.